ArticleBMC medicine2018
Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants.
Article in BMC medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.
- Facilitators and barriers to tuberculosis active case findings in low- and middle-income countries: a systematic review of qualitative research.BMC infectious diseases · 2023Pooled it
- Risk factors for hospital readmission of multidrug-resistant tuberculosis: evidence of longitudinal follow-up data in Ningbo, China.Frontiers in public health · 2025Article
- The unmet surgical needs of global refugee populations: A perspective review.SAGE open medicine · 2023Review
- Optimising tuberculosis care for refugees affected by armed conflicts.The Lancet. Respiratory medicine · 2022Article
- Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we?PLOS global public health · 2022Article
- Influence of Public Health Services on the Goal of Ending Tuberculosis: Evidence From Panel Data in China.Frontiers in public health · 2022Article
- Catch-22: War, Refugees, COVID-19, and the Scourge of Antimicrobial Resistance.Frontiers in medicine · 2022Article
- Is deployement of diagnostic test alone enough? Comprehensive package of interventions to strengthen TB laboratory network: three years of experience in Burkina Faso.BMC infectious diseases · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
By the end of 2017, an estimated 68.5 million people were displaced from their homes worldwide, of whom 25.4 million were refugees. The transmission and globalization of multi-drug resistant tuberculosis during refugee migration is a now priority issue in the public health agenda. Political and scientific commitment at the highest national and international levels will be critical to intensifying action in promoting improved health services for migrants and refugees.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.